Finally, the authors tested the potential of CLAVEEVSL as a target for TCR gene transfer and found that T cells transduced with the TCR for mutant NPM1 resulted in killing of NPM1-mutant AML cells in vitro and in vivo, notably, with a survival benefit observed in the latter experiments (144). The gene discussed is NPM1; the disease is acute myeloid leukemia.